Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care
U Zifko, K Guendling, R Seet, S Kasper - Frontiers in Pharmacology, 2024 - frontiersin.org
Introduction: Although post-COVID-19 syndrome (PCS) with cognitive impairment is
increasingly encountered in primary care, evidence-based recommendations for its …
increasingly encountered in primary care, evidence-based recommendations for its …
MRI evidence of gray matter loss in COVID‐19 patients with cognitive and olfactory disorders
S Capelli, A Arrigoni, A Napolitano… - Annals of Clinical …, 2024 - Wiley Online Library
Objective The aim of this study was to assess COVID‐19‐related gray matter (GM) structural
alterations in two distinct groups of patients presenting with the prevailing and distinctive …
alterations in two distinct groups of patients presenting with the prevailing and distinctive …
Author response to Comment on: Cytokines (IL1β, IL6, TNFα) and serum cortisol levels may not constitute reliable biomarkers to identify individuals with post-acute …
M Fleischer, F Szepanowski… - Therapeutic …, 2024 - journals.sagepub.com
Regarding the statistical analysis, we agree that with F tests in multiple comparisons, such
as Kruskal–Wallis–ANOVA, the post hoc test is not required when the initial test does not …
as Kruskal–Wallis–ANOVA, the post hoc test is not required when the initial test does not …